J Korean Soc Matern Child Health.  2023 Jul;27(3):148-153. 10.21896/jksmch.2023.27.3.148.

Screening and Management of Thyroid Dysfunction During Pregnancy

• Lee S
• Kim SC

• KMID: 2544768
• DOI: http://doi.org/10.21896/jksmch.2023.27.3.148

Abstract

Thyroid hormone is known to play a crucial role in implantation and embryonic development, as well as in the development of the nervous and musculoskeletal systems of fetus. In particular, thyroid dysfunction is associated with various pregnancy-related complications such as miscarriage, preterm birth, fetal growth restriction, and preeclampsia. Previous studies have primarily focus on the adverse effects of hypothyroidism on fetal neurodevelopment. However, the physiological and metabolic alterations occurring during pregnancy in thyroid physiology make it difficult to diagnose thyroid dysfunction. Therefore, obstetricians should have a comprehensive understanding of physiological changes of the thyroid and be familiar with the latest guidelines regarding the complications and management of thyroid dysfunction during pregnancy.

Keyword

Thyroid hormone, Dysfunction, Pregnancy, Fetus

Reference

Abalovich M., Amino N., Barbour LA., Cobin RH., De Groot LJ., Glinoer D, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007. 92(8 Suppl):S1–47.

Ain KB., Mori Y., Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab. 1987. 65:689–96.

Alexander EK., Pearce EN., Brent GA., Brown RS., Chen H., Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017. 27:315–89.

American College of Obstetricians and Gynecologists. Thyroid disease in pregnancy: ACOG practice bulletin summary, number 223. Obstet Gynecol. 2020. 135:1496–9.

Andersen SL., Olsen J., Wu CS., Laurberg P. Severity of birth defects after propylthiouracil exposure in early pregnancy. Thyroid. 2014. 24:1533–40.

Baskin HJ., Cobin RH., Duick DS., Gharib H., Guttler RB., Kaplan MM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002. 8:457–69.

Casey BM., Dashe JS., Wells CE., McIntire DD., Byrd W., Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005. 105:239–45.

Casey BM., Thom EA., Peaceman AM., Varner MW., Sorokin Y., Hirtz DG, et al. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med. 2017. 376:815–25.

Chen S., Zhou X., Zhu H., Yang H., Gong F., Wang L, et al. Preconception TSH and pregnancy outcomes: a population-based cohort study in 184 611 women. Clin Endocrinol. 2017. 86:816–24.

Cleary-Goldman J., Malone FD., Lambert-Messerlian G., Sullivan L., Canick J., Porter TF, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008. 112:85–92.

Clementi M., Di Gianantonio E., Pelo E., Mammi I., Basile RT., Tenconi R. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet. 1999. 83:43–6.

Davis LE., Lucas MJ., Hankins GD., Roark ML., Cunningham FG. Thyro toxicosis complicating pregnancy. Am J Obstet Gynecol. 1989. 160:63–70.

Gharib H., Cobin RH., Dickey RA. Subclinical hypothyroidism during pregnancy: position statement from the American Association of Clinical Endocrinologists. Endocr Pract. 1999. 5:367–8.

Glinoer D., de Nayer P., Bourdoux P., Lemone M., Robyn C., van Steirteghem A, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab. 1990. 71:276–87.

Haddow JE., Palomaki GE., Allan WC., Williams JR., Knight GJ., Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999. 341:549–55.

Hales C., Taylor PN., Channon S., McEwan K., Thapar A., Langley K, et al. Controlled antenatal thyroid screening II: effect of treating maternal suboptimal thyroid function on child behavior. J Clin Endocrinol Metab. 2020. 105:dgz098.

Kim HJ., Cho YY., Kim SW., Kim TH., Jang HW., Lee SY, et al. Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area. Korean J Intern Med. 2018. 33:552–60.

Lazarus J. Thyroid regulation and dysfunction in the pregnant patient. Feingold KR, Anawalt B, Blackman MR, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.;2000. [updated 2016 Jul 21; cited 2023 Jun 7]. Available from: https://www.thyroidmanager.org.

Lazarus JH., Bestwick JP., Channon S., Paradice R., Maina A., Rees R, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012. 366:493–501.

Millar LK., Wing DA., Leung AS., Koonings PP., Montoro MN., Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994. 84:946–9.

Moleti M., Di Mauro M., Sturniolo G., Russo M., Vermiglio F. Hyperthyroidism in the pregnant woman: Maternal and fetal aspects. J Clin Transl Endocrinol. 2019. 16:100190.

Moon HW., Chung HJ., Park CM., Hur M., Yun YM. Establishment of trimester-specific reference intervals for thyroid hormones in Korean pregnant women. Ann Lab Med. 2015. 35:198–204.

Negro R., Mestman JH. Thyroid disease in pregnancy. Best Pract Res Clin Endocrinol Metab. 2011. 25:927–43.

Pop VJ., Brouwers EP., Vader HL., Vulsma T., van Baar AL., de Vijlder JJ. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf). 2003. 59:282–8.

Stagnaro-Green A. Clinical review 152: Postpartum thyroiditis. J Clin Endocrinol Metab. 2002. 87:4042–7.

van den Boogaard E., Vissenberg R., Land JA., van Wely M., van der Post JA., Goddijn M, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2011. 17:605–19.

Yoshihara A., Noh J., Yamaguchi T., Ohye H., Sato S., Sekiya K, et al. Treatment of graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab. 2012. 97:2396–403.